Alpine Immune Sciences, Inc.

VANGUARD GROUP INC

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/10/2024

Shares

2,712,285

Value ($000)

107,515

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/10/2024	107,515	0.0%	2,712,285	3/31/2024
2023 Q4	3/11/2024	42,595	0.0%	2,234,767	12/31/2023
2023 Q3	12/18/2023	16,887	0.0%	1,474,879	9/30/2023
2023 Q2	8/14/2023	14,433	0.0%	1,403,967	6/30/2023
2023 Q1	7/14/2023	10,574	0.0%	1,369,709	3/31/2023
2022 Q4	2/10/2023	10,000	0.0%	1,360,503	12/31/2022
2022 Q3	11/14/2022	8,084	0.0%	1,122,800	9/30/2022
2022 Q2	8/12/2022	5,359	0.0%	629,773	6/30/2022
2022 Q1	5/13/2022	6,347	0.0%	707,598	3/31/2022
2021 Q4	2/14/2022	9,664	0.0%	697,754	12/31/2021
2021 Q3	11/12/2021	6,194	0.0%	580,478	9/30/2021
2021 Q2	8/13/2021	5,176	0.0%	575,217	6/30/2021
2021 Q1	5/14/2021	6,099	0.0%	575,343	3/31/2021
2020 Q4	2/12/2021	6,900	0.0%	547,643	12/31/2020
2020 Q3	11/16/2020	2,785	0.0%	316,891	9/30/2020
2020 Q2	8/14/2020	1,816	0.0%	187,043	6/30/2020
2020 Q1	5/15/2020	538	0.0%	187,043	3/31/2020
2019 Q4	2/14/2020	718	0.0%	187,043	12/31/2019